Wall Street Zen upgraded shares of Cosmos Health (NASDAQ:COSM – Free Report) to a hold rating in a research report report published on Saturday,Wall Street Zen reports.
Several other research analysts also recently weighed in on COSM. Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 28th. Noble Financial assumed coverage on shares of Cosmos Health in a research report on Monday, October 26th. They issued an “outperform” rating for the company. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.
Read Our Latest Stock Analysis on COSM
Cosmos Health Trading Down 22.0%
Cosmos Health (NASDAQ:COSM – Get Free Report) last issued its quarterly earnings results on Tuesday, August 18th. The company reported ($2.00) earnings per share for the quarter, hitting analysts’ consensus estimates of ($2.00). Cosmos Health had a negative return on equity of 56.88% and a negative net margin of 33.08%. The firm had revenue of $19.32 million for the quarter, compared to analysts’ expectations of $18.99 million. Research analysts predict that Cosmos Health will post -0.15 earnings per share for the current year.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Cosmos Health stock. BlackRock Inc. bought a new stake in shares of Cosmos Health Inc. (NASDAQ:COSM – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 267,797 shares of the company’s stock, valued at approximately $49,000. BlackRock Inc. owned 0.45% of Cosmos Health as of its most recent SEC filing. 12.61% of the stock is owned by hedge funds and other institutional investors.
Cosmos Health Company Profile
Cosmos Health Inc. is a healthcare group focused on pharmaceutical distribution, branded consumer health products and related services. Its activities include supplying pharmaceutical products and other healthcare goods to pharmacies and healthcare providers, as well as developing and marketing nutraceuticals and wellness products. The company’s consumer brands include Sky Premium Life, which offers vitamins and dietary supplements, and Mediterranation, a personal-care and skincare line. Its operations are centered in Greece, with business and distribution activities extending to other international markets.
Further Reading
- Five stocks we like better than Cosmos Health
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.
